Ekos, the Bothell, WA-based company that uses ultrasound to treat vascular diseases, said today it has received a $2.7 million grant from the National Institutes of Health to study its method of treating hemorrhagic strokes. About 100,000 patients in the U.S. have this condition, in which a blood vessel ruptures in the brain and creates dangerous swelling and clots. Ekos, with the help of neurosurgeon David Newell at Swedish Medical Center, has worked to deliver its tiny ultrasound probe into the brain where it is supposed to help loosen up the clot and make clot-dissolving drugs more effective.
Author: Luke Timmerman
Luke is an award-winning journalist specializing in life sciences. He has served as national biotechnology editor for Xconomy and national biotechnology reporter for Bloomberg News. Luke got started covering life sciences at The Seattle Times, where he was the lead reporter on an investigation of doctors who leaked confidential information about clinical trials to investors. The story won the Scripps Howard National Journalism Award and several other national prizes. Luke holds a bachelor’s degree in journalism from the University of Wisconsin-Madison, and during the 2005-2006 academic year, he was a Knight Science Journalism Fellow at MIT.
View all posts by Luke Timmerman
